Moffitt Uses Biosamples to Improve Trial Efficiency

May 13, 2013 | According to researchers at Total Care Cancer (a comprehensive approach to cancer launched at Moffitt Cancer Center), using biosamples for phase II cancer trials improves research efficiency, cost, and the rate of drug development. Using a patient’s biological and molecular profile, researchers at Total Care Cancer can identify potential candidates for clinical trials. This study was published March 15 in Statistical Methods in Medical Research. News Medical


Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact Angela Parsons, 781.972.5467.